Login
← Go Back
Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com
Stock Price vs Company Growth
1d
2.4%
1w
4.0%
1m
3.1%
3m
2.8%
6m
1.1%
1y
29.6%
5y
3.1%
10y
13.4%
all
14.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 631 2.4%
606
684
Company Overview
Sales
3,747 Cr
Growth: 7.7%
Profit after Tax
468 Cr
Growth: -7.7%
Mid Cap
25,434 Cr
P/E: 54.2x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 3,747
Growth 7.7%
EBITDA 27.5%
P/S 6.8x
Dividend 0.2%
P/E 54.2x
Book Value ₹ 121
PEG Ratio 7.0x
ROE 9.9%
P/B 5.2x
Shareholding Pattern
Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.
Belongs to (26 Indices) view more
Investors (435)
mahesh.g...
ajit.man...
arshad.j...
Followers (15)
yogesh
nitin2
keerthi